
Keywords: 5FU; fluorouracil 5%; CMOBC; cutaneous metastases of breast cancer; MBC; metastatic breast cancer; TLR7; toll-like receptor 7; antitumor immunity; breast cancer; cryotherapy; cutaneous metastases; fluorouracil; imiquimod; in situ vaccination; skin-direct